The Chemours Newsroom

Chemours Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesNov 5 21:32

Chemours Analyst Ratings

BenzingaNov 5 21:22

Barclays Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $23

Futu NewsNov 5 17:39

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating

Futu NewsNov 5 14:32

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Futu NewsNov 5 10:34

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Futu NewsOct 15 02:31

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $28

Futu NewsOct 11 21:31

UBS Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $26

Futu NewsOct 9 00:31

UBS Adjusts The Chemours Price Target to $26 From $28, Maintains Buy Rating

MT NewswiresOct 7 22:52

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 7 21:31

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Raises Target Price to $32

Futu NewsOct 7 19:31

Chemours Is Maintained at Equal-Weight by Barclays

Dow JonesSep 25 23:50

Chemours Analyst Ratings

BenzingaSep 25 23:40

巴克莱银行维持The Chemours(CC.US)持有评级，下调目标价至21美元

Futu NewsSep 25 17:33

Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $23

Futu NewsSep 4 00:31

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Futu NewsAug 6 21:33

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $22

BenzingaAug 6 21:13

Chemours Analyst Ratings

BenzingaAug 6 19:55

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $30

Futu NewsAug 6 19:34

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Futu NewsAug 6 18:31